<SEC-DOCUMENT>0001104659-25-014191.txt : 20250214
<SEC-HEADER>0001104659-25-014191.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214163151
ACCESSION NUMBER:		0001104659-25-014191
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214
EFFECTIVENESS DATE:		20250214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AbbVie Inc.
		CENTRAL INDEX KEY:			0001551152
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				320375147
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284980
		FILM NUMBER:		25629738

	BUSINESS ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
		BUSINESS PHONE:		(847) 932-7900

	MAIL ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>tm255723-1_s3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
<html>
  <head>
    <title>tm255723-1_s3asr - none - 2.9062819s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">As filed with the Securities and Exchange Commission on February&#160;14, 2025</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:0.7pt; text-align:right; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">No. 333-&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font>&#8203;</div>
        <div style="margin-top:1.2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.2pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.7pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.7pt; text-align:center; width:541.31pt; line-height:16.5pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">UNITED STATES </font>
          <br >
          <font style="letter-spacing:-0.32pt;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:0.7pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:8.2pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.2pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:16.5pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">FORM S-3</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:0.7pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">REGISTRATION STATEMENT </font>
          <br >
          <font style="letter-spacing:-0.18pt;">UNDER </font>
          <br >
          <font style="letter-spacing:-0.18pt;">THE SECURITIES ACT OF 1933</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:8.2pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.19999999999999pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:16.5pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">ABBVIE INC.</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:0.69pt; text-align:center; width:541.31pt; line-height:8.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Exact name of registrant as specified in its charter) </font>
        </div>
        <table style="width:541.31pt;margin-top:4.69999999999999pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
          <tr style="line-height:10.8pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:264.66pt;">
              <div style="text-align:center;font-weight:bold;font-size:9pt;">
                <font style="letter-spacing:-0.18pt;">Delaware</font>
              </div>
              <div style="margin-top:1.8pt; text-align:center; line-height:9pt;">
                <font style="letter-spacing:0.16pt;">(State or other jurisdiction </font>
                <br >
                <font style="letter-spacing:0.16pt;">of incorporation or organization)</font><font style="font-size:9pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:264.65pt;">
              <div style="text-align:center;font-weight:bold;font-size:9pt;">
                <font style="letter-spacing:-0.18pt;">32-0375147</font>
              </div>
              <div style="margin-top:1.8pt; text-align:center; line-height:9pt;">
                <font style="letter-spacing:0.16pt;">(I.R.S. Employer </font>
                <br >
                <font style="letter-spacing:0.16pt;">Identification No.)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">1 North Waukegan Road </font>
          <br >
          <font style="letter-spacing:-0.18pt;">North Chicago, Illinois 60064-6400 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">(847) 932-7900</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:0.7pt; text-align:center; width:541.31pt; line-height:8.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices) </font>
        </div>
        <div style="margin-top:8.19pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.19pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Perry C. Siatis, Esq. </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Executive Vice President, General Counsel and Secretary </font>
          <br >
          <font style="letter-spacing:-0.18pt;">AbbVie Inc. </font>
          <br >
          <font style="letter-spacing:-0.18pt;">1 North Waukegan Road </font>
          <br >
          <font style="letter-spacing:-0.18pt;">North Chicago, Illinois 60064-6400 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">(847) 932-7900</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:0.7pt; text-align:center; width:541.31pt; line-height:8.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service) </font>
        </div>
        <div style="margin-top:8.19pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.19pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:9.5pt;font-style:italic;">
          <font style="letter-spacing:0.18pt;">Copies of all communications, including communications sent to agent for service, should be sent to:</font><font style="font-style:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Sophia Hudson, P.C. </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Zoey Hitzert </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Kirkland &amp; Ellis LLP </font>
          <br >
          <font style="letter-spacing:-0.18pt;">601 Lexington Avenue </font>
          <br >
          <font style="letter-spacing:-0.18pt;">New York, NY 10022 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">United States </font>
          <br >
          <font style="letter-spacing:-0.18pt;">(212) 446-4800</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Approximate date of commencement of proposed sale to the public:</font><font style="font-weight:normal;letter-spacing:0.18pt;"> From time to time after the effective date of this Registration Statement. </font>
        </div>
        <div style="margin-top:8.2pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.19999999999999pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:6.7pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:&#160;&#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </font>
        </div>
        <table style="width:521.31pt;height:33.5699999999999pt;margin-left:20pt;margin-top:4.70000000000005pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
          <tr style="line-height:8.97000000000003pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:254.66pt;">
              <div style=" float:left; line-height:9pt; text-align:left; width:113pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Large accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:113pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.18pt;">&#9746; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:254.65pt;">
              <div style=" float:left; line-height:9pt; text-align:left; width:132pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:132pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.18pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.52pt 0pt 0.79pt 0pt; width:254.66pt;">
              <div style=" float:left; line-height:9pt; text-align:left; width:113pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Non-accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:113pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.18pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.52pt 0pt 0.79pt 0pt; width:254.65pt;">
              <div style=" float:left; line-height:9pt; text-align:left; width:132pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Smaller reporting company</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:132pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.18pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:254.66pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.79pt 0pt; width:254.65pt;white-space:normal;">
              <div style=" float:left; line-height:9pt; text-align:left; width:132pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Emerging growth company</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:132pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.18pt;">&#9744;</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of Securities Act. &#9744; </font>
        </div>
        <div style="margin-top:5.2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 5.20000000000005pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.69pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.68999999999994pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:14pt; text-align:center; width:456pt;">
          <img src="lg_abbvie-4c.jpg" alt="[MISSING IMAGE: lg_abbvie-4c.jpg]" height="54" width="310" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">ABBVIE INC.</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Debt Securities</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus relates to the sale of one or more series of debt securities of AbbVie Inc., a Delaware corporation (&#8220;AbbVie,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or the &#8220;Company&#8221;), from time to time, on terms and at prices determined at the time the debt securities are offered for sale. The terms and prices will be described in more detail in one or more supplements to this prospectus. Before investing, you should carefully read this prospectus and any related prospectus supplement or free writing prospectus. Prospectus supplements or free writing prospectuses may also add, update, or change information contained in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may offer and sell these securities to or through agents, underwriters, dealers, or directly to purchasers on a continuous or a delayed basis. The names of any agents, underwriters, or dealers and the terms of the arrangements with such entities will be stated in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing in our securities involves risks. See &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">Risk Factors</font><font style="letter-spacing:-0.2pt;">&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024 (the &#8220;2024 Annual Report&#8221;), in our subsequent periodic filings with the Securities and Exchange Commission (the &#8220;SEC&#8221;) incorporated by reference in this prospectus and in the applicable prospectus supplement or any related free writing prospectuses that we have authorized for use in connection with a specific offering.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:280pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prospectus dated February&#160;14, 2025.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:417.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:173.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tATP"><font style="letter-spacing:0.2pt;">About this Prospectus </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tATP">1</a></font> <a href="#tATP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tFOST"><font style="letter-spacing:0.2pt;">Forward-Looking Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFOST">2</a></font> <a href="#tFOST"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:0.2pt;">Prospectus Summary </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSU">3</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tIIBR"><font style="letter-spacing:0.2pt;">Information Incorporated by Reference </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIIBR">4</a></font> <a href="#tIIBR"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">Where You Can Find More Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">5</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">Risk Factors </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">6</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">Use of Proceeds </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUOP">7</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDODS"><font style="letter-spacing:0.2pt;">Description of Debt Securities </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDODS">8</a></font> <a href="#tDODS"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPOD"><font style="letter-spacing:0.2pt;">Plan of Distribution </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPOD">10</a></font> <a href="#tPOD"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:0.2pt;">Legal Matters </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEMA">12</a></font> <a href="#tLEMA"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">Experts </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXP">12</a></font>
            </td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tATP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:260pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of an automatic shelf registration statement that we filed with the SEC as a &#8220;well known seasoned issuer&#8221; as defined in Rule&#160;405 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), using a &#8220;shelf&#8221; registration process. Using this process, we may offer and sell debt securities described in this prospectus in one or more offerings from time to time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have not authorized anyone to give any information or to make any representations concerning the debt securities we may offer except those which are in this prospectus, any prospectus supplement that is delivered with this prospectus, any related free writing prospectus that we authorize, or any documents incorporated by reference into this prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information or representations that others may give or make to you. This prospectus is not an offer to sell or a solicitation of an offer to buy any securities other than the debt securities that are referred to in the prospectus supplement. This prospectus is not an offer to sell or a solicitation of an offer to buy debt securities in any circumstances in which the offer or solicitation is unlawful. You should not interpret the delivery of this prospectus, or any offer or sale of debt securities, as an indication that there has been no change in our affairs since the date of this prospectus.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus provides you with a general description of debt securities we may offer. Each time we sell debt securities described in this prospectus, we will provide a prospectus supplement or free writing prospectus that will contain specific information about the terms of that offering and the debt securities being offered at that time. The prospectus supplement or free writing prospectus also may add, update or change information contained in this prospectus, and any statement in this prospectus will be modified or superseded by any inconsistent statement in a prospectus supplement or free writing prospectus. You should read both this prospectus and any prospectus supplement or free writing prospectus together with the additional information described under the headings &#8220;Where You Can Find More Information&#8221; and &#8220;Information Incorporated by Reference.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should not assume that the information in this prospectus or any applicable prospectus supplement or any related free writing prospectus is accurate as of any date other than the date on the cover of the applicable document. Our business, financial condition, results of operations and prospects may have changed since that date. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tFOST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:416pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Some statements in this prospectus, any prospectus supplement, any free writing prospectus and the documents incorporated herein by reference are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (&#8220;PSLRA&#8221;). The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;project&#8221; and similar expressions and uses of future or conditional verbs, generally identify &#8220;forward looking statements,&#8221; which speak only as of the date the statements were made. The matters discussed in these forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed or implied, such expectation or belief is based on the current plans and expectations of AbbVie management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie&#8217;s operations is set forth in Item&#160;1A, &#8220;Risk Factors,&#8221; in the 2024 Annual Report, which has been filed with the SEC. AbbVie notes these factors for investors as permitted by the PSLRA. AbbVie does not undertake, and specifically declines, any obligation to update the forward-looking statements included in this prospectus to reflect events or circumstances after the date hereof, unless AbbVie is required by applicable securities law to do so.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider before investing in our debt securities. You should read the following summary together with the more detailed information regarding our Company, the securities being registered hereby and our financial statements and notes thereto incorporated by reference into this prospectus. </font>
          </div>
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">AbbVie Inc.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AbbVie is a global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio that has leadership positions across immunology, oncology, neuroscience, aesthetics and eye care. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world&#8217;s most complex and serious diseases. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AbbVie was incorporated in Delaware on April&#160;10, 2012. On January&#160;1, 2013, AbbVie became an independent, publicly traded company as a result of the distribution by Abbott Laboratories (&#8220;Abbott&#8221;) of 100% of the outstanding common stock of AbbVie to Abbott&#8217;s shareholders. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AbbVie also maintains an Internet site at www.abbvie.com. AbbVie&#8217;s website and the information contained therein or connected thereto shall not be deemed to be incorporated herein, and you should not rely on any such information in making an investment decision. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The address of AbbVie&#8217;s principal executive offices is 1 North Waukegan Road, North Chicago, Illinois 60064-6400. AbbVie&#8217;s telephone number is (847) 932-7900.</font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIIBR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:64pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION INCORPORATED BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows us to &#8220;incorporate by reference&#8221; the information we file with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus, and information that we file later with the SEC will automatically update and supersede information included or previously incorporated by reference into this prospectus from the date we file the document containing such information. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. Except to the extent furnished and not filed with the SEC pursuant to Item&#160;2.02 or 7.01 of Form 8-K or as otherwise permitted by the SEC rules, we incorporate by reference the documents listed below and any future filings we will make with the SEC under Section&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), from the date of this prospectus until the completion of the offering in the relevant prospectus supplement to which this prospectus relates or the offering is terminated. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The documents we incorporate by reference into this prospectus are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;"><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm">Annual Report on Form 10-K for the year ended December&#160;31, 2024, as filed with the SEC on February&#160;14, 2025;</a> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The information in Part&#160;III of the <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115224000011/abbv-20231231.htm">Annual Report on Form 10-K for the year ended December&#160;31, 2023, as filed with the SEC on February&#160;20, 2024,</a> incorporated by reference from the Company&#8217;s <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155837024003496/abbv-20240503xdef14a.htm">Definitive Proxy Statement on Schedule&#160;14A, as filed with the SEC on March&#160;18, 2024</a>; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Company&#8217;s Current Reports on Form 8-K as filed with the SEC on <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115225000006/abbv-20250109.htm">January&#160;10, 2025</a>, <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000110465925009673/tm255474d1_8k.htm">February&#160;5, 2025</a> and <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001551152/000110465925013467/tm256372d1_8k.htm">February 14, 2025</a>. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of a registration statement on Form S-3 filed with the SEC under the Securities Act. This prospectus does not contain all of the information set forth in the registration statement. You should read the registration statement for further information about AbbVie and our debt securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Documents incorporated by reference into this prospectus are available from us, without charge, excluding all exhibits unless specifically incorporated by reference in the documents. You may obtain documents incorporated by reference into this prospectus by writing to us at the following address or by calling us at the telephone number listed below: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AbbVie Inc.</font>
          <br >
          <font style="letter-spacing:0.2pt;">1 North Waukegan Road</font>
          <br >
          <font style="letter-spacing:0.2pt;">North Chicago, Illinois 60064-6400</font>
          <br >
          <font style="letter-spacing:0.2pt;">Attention: Investor Relations</font>
          <br >
          <font style="letter-spacing:0.2pt;">(847) 932-7900</font>
          <br >
          <font style="letter-spacing:0.2pt;">http://investors.abbvie.com </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have not authorized anyone to provide you with any information other than that contained or incorporated by reference into this prospectus, any accompanying prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you and take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date on the front page of those documents. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:492pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have filed with the SEC a registration statement on Form S-3 with respect to the debt securities offered hereby. This prospectus does not contain all the information set forth in the registration statement, parts of which are omitted in accordance with the rules and regulations of the SEC. For further information with respect to us and the debt securities offered hereby, reference is made to the registration statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We file annual, quarterly and special reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet from the SEC&#8217;s website at www.sec.gov, or our website at www.abbvie.com. Our website and the information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus or the registration statement of which this prospectus forms a part and you should not rely on any such information in making your investment decision. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:480pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investing in our debt securities involves risks. You should carefully consider the risks described under &#8220;Risk Factors&#8221; beginning on page 14 of our 2024 Annual Report, which is incorporated by reference herein, as well as the other information contained or incorporated by reference into this prospectus or any prospectus supplement hereto before making a decision to invest in our debt securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our business, financial condition, results of operations, and cash flows could be materially adversely affected by any of these risks. The market or trading price of our debt securities could decline due to any of these risks. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business and operations or cause the price of our debt securities to decline. In addition, past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:560pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Except as may be described otherwise in a prospectus supplement, we expect to use the net proceeds from the sale of the debt securities under this prospectus for future acquisitions, stock repurchases, the repayment of indebtedness, capital expenditures, dividends, working capital, and any other general corporate purpose. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDODS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF DEBT SECURITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following description, together with the additional information that may be included in any applicable prospectus supplement and in any related free writing prospectuses, summarizes the material terms and provisions of the debt securities that AbbVie may offer under this prospectus. While the terms summarized below will apply generally to any debt securities that AbbVie may offer, the particular terms of any debt securities will be described in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">AbbVie may issue debentures, notes or other evidences of indebtedness, which we refer to as &#8220;debt securities,&#8221; from time to time in one or more distinct series. The debt securities may be senior debt securities or subordinated debt securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The debt securities will be governed by an indenture, dated as of November&#160;8, 2012 (the &#8220;indenture&#8221;), between AbbVie and U.S. Bank Trust Company, National Association, as trustee. The indenture is subject to and governed by the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). The trustee under the indenture has two main roles: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">first, subject to some limitations, the trustee can enforce your rights against us if we default; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">second, the trustee performs certain administrative duties for us, which include sending you notices and, if the trustee also performs the service of paying agent, interest payments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">The specific terms of debt securities being offered will be described in the applicable prospectus supplement. </font><font style="letter-spacing:0.2pt;">As you read this section, please remember that the specific terms of your debt securities as described in the applicable prospectus supplement will supplement and, if applicable, may modify or replace the general terms described in this section. If there are any differences between the applicable prospectus supplement and this prospectus, the applicable prospectus supplement will control. Thus, the statements we make in this section may not apply to your debt security.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The statements and descriptions in this prospectus or in any prospectus supplement or any document incorporated by reference into this prospectus or the applicable prospectus supplement regarding provisions of debt securities and the indenture are summaries of those provisions, do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the debt securities and the indenture (including any amendments or supplements AbbVie may enter into from time to time which are permitted under the debt securities or the indenture). You should read the summary below, the applicable prospectus supplement, the indenture and any related documents before making your investment decision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The applicable prospectus supplement will set forth the terms of the debt securities or any series thereof, including, if applicable: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the title of the debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any limit upon the aggregate principal amount of the debt securities of the series which may be authenticated and delivered under the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the person to whom any interest on the debt securities of the series shall be payable, if other than the person in whose name the debt securities (or one or more predecessor debt securities) is registered at the close of business on the regular record date for such interest; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the date or dates on which the principal of the debt securities of the series is payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rate or rates at which the debt securities of the series shall bear interest, if any, or the method of calculating such rate or rates of interest, and the date or dates from which such interest shall accrue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the dates on which any such interest shall be payable and the regular record date for any interest payable on any such date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the place or places where the principal of and any premium and interest on the debt securities of the series shall be payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the period or periods within which the price or prices at which and the terms and conditions upon which the debt securities of the series may be redeemed, in whole or in part, at AbbVie&#8217;s option; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the obligation, if any, of AbbVie to redeem, purchase or repay the debt securities of the series pursuant to any sinking fund or analogous provisions or at the option of a holder thereof and the period or periods within which the price or prices at which and the terms and conditions upon which the debt securities of the series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if other than denominations of $2,000 and any integral multiple of $1,000 in excess thereof, the denominations in which the debt securities of the series shall be issuable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the currency, currencies or currency&#160;units in which payment of the principal of and any premium and interest on the debt securities of the series shall be payable if other than the currency of the United States of America and the manner of determining the equivalent thereof in the currency of the United States of America for purposes of the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the amount of payments of principal of or any premium or interest on any debt securities of the series may be determined with reference to an index or formula, the manner in which such amounts shall be determined; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the principal of or any premium or interest on the debt securities of the series is to be payable, at the election of AbbVie or a holder thereof, in one or more currencies or currency&#160;units other than that or those in which the debt securities are stated to be payable, the currency, currencies or currency&#160;units in which payment of the principal of and any premium and interest on the debt securities of such series as to which such election is made shall be payable, and the periods within which and the terms and conditions upon which such election is to be made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the application, if any, of the provisions for the defeasance or covenant defeasance of the indenture to the debt securities of any series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether the debt securities of the series shall be issued in whole or in part in the form of one or more global securities and, in such case, the depositary with respect to such global security or securities and the circumstances under which any global security may be registered for transfer or exchange, or authenticated and delivered, in the name of a person other than such depositary or its nominee; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if other than the principal amount thereof, the portion of the principal amount of the debt securities of the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant to the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether payment of any amount due under the debt securities will be guaranteed by one or more guarantors, including one or more of our subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether the debt securities will be secured or unsecured; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the forms of the debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a discussion of any material United States federal income tax consequences of owning and disposing of the debt securities; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other terms of the debt securities of the series (which terms shall not be inconsistent with the provisions of the indenture, except as permitted thereunder). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of a registration statement that provides that AbbVie may issue debt securities from time to time in one or more series under the indenture, in each case with the same or various maturities, at par or at a discount. Unless otherwise indicated in the applicable prospectus supplement, the aggregate principal amount of debt securities that may be issued under the applicable indenture is unlimited. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The indenture contains certain restrictive covenants that will apply to AbbVie and its subsidiaries unless otherwise indicated in the applicable prospectus supplement. Unless otherwise indicated in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell debt securities to or through underwriters and also directly to other purchasers or through agents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The distribution of the debt securities offered under this prospectus may occur from time to time in one or more transactions at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the sale of debt securities, underwriters may receive compensation from us or from purchasers of debt securities for whom they may act as agents in the form of discounts, concessions, or commissions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Underwriters may sell debt securities to or through dealers, and such dealers may receive compensation in the form of discounts, concessions, or commissions from the underwriters, and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers, and agents that participate in the distribution of debt securities offered under this prospectus may be &#8220;underwriters,&#8221; as defined in the Securities Act. Any underwriters or agents will be identified and their compensation (including underwriting discount) will be described in the applicable prospectus supplement. The prospectus supplement will also describe the other terms of the offering, including any discounts or concessions allowed or re-allowed or paid to dealers and any securities exchanges on which the offered securities may be listed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may have agreements with the underwriters, dealers, and agents to indemnify them against certain liabilities, including certain liabilities under the Securities Act, or to contribute with respect to payments which the underwriters, dealers, or agents may be required to make as a result of those liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the applicable prospectus supplement indicates, we may authorize dealers or agents to solicit offers by certain institutions to purchase debt securities from us pursuant to contracts that provide for payment and delivery on a future date. We must approve all institutions, but they may include, among others: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">commercial and savings banks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">insurance companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">pension funds; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">investment companies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">educational and charitable institutions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An institutional purchaser&#8217;s obligation under the contract will be subject to the condition that the purchase of the offered debt securities at the time of delivery is allowed by the laws that govern such purchaser. The dealers and the agents will not be responsible for the validity or performance of the contracts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In general, the debt securities will be a new issue of securities and will have no established trading market. Any underwriters to whom debt securities are sold for public offering and sale may make a market in the debt securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. The debt securities may or may not be listed on a national securities exchange. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with any offering of the debt securities offered under this prospectus, underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the debt securities or any other securities the prices of which may be used to determine payments on the debt securities. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by underwriters of a greater number of debt securities than the underwriters are required to purchase in the offering. Stabilizing transactions consist of certain bids or purchases made for the purpose of preventing or retarding a decline in the market price of the debt securities while the offering is in progress. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Underwriters may also impose a penalty bid in any offering of debt securities offered under this prospectus and any prospectus supplement through a syndicate of underwriters. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:536pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">because the other underwriters have repurchased debt securities sold by or for the account of such underwriter in stabilizing or short covering transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">These activities by underwriters may stabilize, maintain or otherwise affect the market price of the debt securities offered under this prospectus and any prospectus supplement. As a result, the price of such debt securities may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by underwriters at any time. These transactions may be effected in the over-the-counter market or otherwise. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:456pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise indicated in the applicable prospectus supplement, legal matters in connection with the debt securities offered under this prospectus will be passed upon for us by Kirkland &amp; Ellis LLP, New York, New York, and for any underwriters or agents by counsel named in the applicable prospectus supplement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of AbbVie Inc. appearing in our Annual Report on Form 10-K for the year ended December&#160;31, 2024, and the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2024, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 3pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="position:relative;margin-top:254.5pt; text-align:center; width:456pt;">
          <img src="lg_abbvie-4c.jpg" alt="[MISSING IMAGE: lg_abbvie-4c.jpg]" height="77" width="443" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Debt Securities</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:315.167pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 315.166666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 3pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;14.&nbsp;&nbsp;&nbsp;Other Expenses of Issuance and Distribution.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table is a statement of estimated expenses to be incurred by the registrant in connection with the issuance and distribution of the debt securities being registered under this registration statement. </font>
        </div>
        <table style="width:416pt;height:129pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:343.09pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount to be paid </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC registration fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font><font style="position:absolute;">*</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Rating agency fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printing and engraving fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trustee&#8217;s fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:343.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>**</font>
            </td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pursuant to Rule&#160;456(b) and Rule&#160;457(r), the registrant is deferring payment of the entire SEC registration fee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Because an indeterminate amount of securities is covered by this registration statement, the expenses in connection with the issuance and distribution of securities are not currently determinable. A prospectus supplement will set forth the estimated expenses payable in connection with a particular offering of securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;15.&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As permitted by the Delaware General Corporation Law (the &#8220;DGCL&#8221;), the registrant&#8217;s amended and restated certificate of incorporation provides that a director of the registrant will not be personally liable to the registrant or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for any breach of their duty of loyalty to the registrant or its stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">under Section&#160;174 of the DGCL relating to unlawful payments of dividends or unlawful stock repurchases or redemptions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for any transaction from which the director derived an improper personal benefit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The limitation of liability does not apply to liabilities arising under the federal or state securities laws and does not affect the availability of equitable remedies, such as injunctive relief or rescission. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The registrant&#8217;s amended and restated certificate of incorporation and third amended and restated by-laws include provisions that indemnify, to the fullest extent allowable under the DGCL, the personal liability of directors or officers for monetary damages for actions taken as a director or officer of the registrant, or for serving at the registrant&#8217;s request as a director or officer or another position at another corporation or enterprise, as the case may be. The registrant&#8217;s amended and restated certificate of incorporation and third amended and restated by-laws also provide that the registrant must indemnify and advance reasonable expenses to its directors and officers, subject to its receipt of an undertaking from the indemnified party as may be required under the DGCL. The registrant&#8217;s third amended and restated by-laws expressly authorize the registrant to carry directors&#8217; and officers&#8217; insurance to protect the registrant, its directors, officers and certain employees from some liabilities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing is only a general summary of certain aspects of Delaware law and the registrant&#8217;s amended and restated certificate of incorporation and third amended and restated by-laws dealing with indemnification of directors and officers and does not purport to be complete. It is qualified in its entirety by reference to the detailed provisions of those sections of the DGCL referenced above and the amended and restated certificate of incorporation and third amended and restated by-laws of the registrant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;16.&nbsp;&nbsp;&nbsp;Exhibits.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following exhibits are included herein or incorporated herein by reference: </font>
        </div>
        <table style="width:456pt;height:176.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:27.71pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exhibit</font>
                <br >
                <font style="letter-spacing:-0.16pt;">No. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:416.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Description </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">1.1* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:416.29pt;">
              <font style="letter-spacing:0.2pt;">Form of Underwriting Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:27.71pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:416.29pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1551152/000104746912010673/a2211869zex-4_1.htm">Indenture, dated as of November&#160;8, 2012, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit&#160;4.1 of Amendment No. 5 to the Company&#8217;s Registration Statement on Form 10 filed on November&#160;16, 2012)</a>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1551152/000104746912010673/a2211869zex-4_1.htm">Form of Debt Security (included in Exhibit&#160;4.1)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">5.1** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm255723d2_ex5-1.htm">Opinion of Kirkland &amp; Ellis LLP</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="letter-spacing:0.2pt;">23.1** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm255723d2_ex23-1.htm">Consent of Ernst &amp; Young LLP</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="letter-spacing:0.2pt;">23.2** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm255723d2_ex5-1.htm">Consent of Kirkland &amp; Ellis LLP (included in Exhibit&#160;5.1)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="letter-spacing:0.2pt;">24.1** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a href="#tSIGNA">Power of Attorney (included on the signature page)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="letter-spacing:0.2pt;">25.1** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm255723d2_ex25-1.htm">Form T-1 Statement of Eligibility under the Trust Indenture Act</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:27.71pt;">
              <font style="letter-spacing:0.2pt;">107** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:416.29pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm255723d1_ex-filingfees.htm">Filing Fee Table</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To be filed by amendment or by a Current Report on Form 8-K. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Filed herewith. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;17.&nbsp;&nbsp;&nbsp;Undertakings.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than 20&#160;percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Filing Fee Tables&#8221; table in the effective registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Provided, however,</font><font style="letter-spacing:0.2pt;"> that: </font>
        </div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Paragraphs (a)(1)(i), (ii)&#160;and (iii)&#160;above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:80pt; width:376pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with or furnished to the Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement. </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font><font style="font-style:italic;letter-spacing:0.2pt;">Provided, however</font><font style="letter-spacing:0.2pt;">, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </font>
        </div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:60pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSIGNA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of North Chicago, State of Illinois, on February&#160;14, 2025. </font>
        </div>
        <div style="margin-left:240pt; margin-top:12pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABBVIE INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:260pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Scott T. Reents</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:260pt; margin-top:3pt; width:196pt;">
          <div style="margin-left: 0pt; width: 196pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:260pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:296pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Scott T. Reents </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:260pt; line-height:12pt; margin-top:1.19pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Title:</font>
          <br >
        </div>
        <div style=" margin-top:1.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:296pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Executive Vice President, Chief Financial Officer </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">KNOW ALL PERSONS BY THESE PRESENTS: That each person whose name is signed hereto has made, constituted and appointed, and does hereby make, constitute and appoint, Robert A. Michael, Scott&#160;T. Reents and Perry C. Siatis, and each of them, his or her true and lawful attorney-in-fact, for him or her and in his or her name, place and stead to affix his or her signature as director or officer or both, as the case may be, of the registrant, to any and all registration statements and amendments thereto (including post-effective amendments) and to file the same, with all exhibits thereto, and other documents in connection therewith, and to file with the SEC, granting unto each such attorney-in-fact full power and authority to do and perform every act and thing whatsoever necessary to be done in the premises, as fully as he or she might or could do if personally present, hereby ratifying and confirming all that each such attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act, as amended, this registration statement has been signed by the following persons in the capacities indicated below on February&#160;14, 2025. </font>
        </div>
        <table style="width:456pt;height:324.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;min-height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:54.25pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 0.5pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Robert A. Michael</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Robert A. Michael </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 0.5pt 0pt; width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Chief Executive Officer and Director</font>
                <br >
                <font style="letter-spacing:0.2pt;">(Principal Executive Officer) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Scott T. Reents</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Scott T. Reents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Executive Vice President, Chief Financial Officer</font>
                <br >
                <font style="letter-spacing:0.2pt;">(Principal Financial Officer) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Kevin K. Buckbee</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Kevin K. Buckbee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Senior Vice President, Controller</font>
                <br >
                <font style="letter-spacing:0.2pt;">(Principal Accounting Officer) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Richard A. Gonzalez</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Richard A. Gonzalez </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Executive Chairman of the Board and Retired </font>
                <br >
                <font style="letter-spacing:0.2pt;">Chief Executive Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Robert J. Alpern, M.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Robert J. Alpern, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Roxanne S. Austin</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Roxanne S. Austin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt;white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ William H.L. Burnside</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">William H.L. Burnside </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:196.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:414.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;min-height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:54.25pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 0.5pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Jennifer L. Davis</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Jennifer L. Davis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 0.5pt 0pt; width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Thomas C. Freyman</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Thomas C. Freyman </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Brett J. Hart</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Brett J. Hart </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Melody B. Meyer</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Melody B. Meyer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Susan E. Quaggin, M.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Susan E. Quaggin, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Edward J. Rapp</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Edward J. Rapp </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Rebecca B. Roberts</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Rebecca B. Roberts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:45pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Glenn F. Tilton</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Glenn F. Tilton </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt;white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style=" width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ Frederick H. Waddell</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 222pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Frederick H. Waddell </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style=" width:222pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm255723d2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm255723d2_ex5-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="width: 23%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">601 Lexington Avenue</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">New York, NY 10022</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">United States</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">+1 212 446 4800</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">www.kirkland.com</P></TD>
    <TD STYLE="vertical-align: middle; width: 39%; padding-right: 5.4pt; padding-left: -0.375in; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:<BR>
    +1 212 446 4900</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">February&nbsp;14, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1 North Waukegan Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">North Chicago,&nbsp;Illinois 60064-6400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5%"></TD><TD STYLE="width: 6%">Re:</TD><TD STYLE="width: 89%">AbbVie Inc.<BR>
Registration Statement on Form&nbsp;S-3ASR</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are issuing this opinion letter in our capacity
as special counsel to AbbVie Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the preparation and filing
by the Company of a Registration Statement on Form&nbsp;S-3ASR (the &ldquo;<U>Registration Statement</U>&rdquo;) with the Securities and
Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) to&nbsp;register an indeterminate amount of debt securities (collectively, the
 &ldquo;<U>Debt Securities</U>&rdquo;), which may be issued from time to time on a delayed or continuous basis pursuant to Rule&nbsp;415
under the Securities Act of 1933, as amended (the &ldquo;<U>Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the registration of the Debt
Securities, we have examined originals, or copies certified or otherwise <FONT STYLE="background-color: white">identified to our satisfaction,
of such documents, corporate records and other instruments as we have deemed necessary for the purposes of this opinion, including (i)&nbsp;the
Amended and Restated Certificate of Incorporation of the Company, as amended through the date hereof, (ii)&nbsp;the Third Amended and
Restated Bylaws of the Company, as amended through the date hereof, (iii)&nbsp;minutes and records of the corporate proceedings of the
Company and (iv)&nbsp;the Registration Statement and the exhibits thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">For purposes
of this opinion, we have assumed the authenticity of all documents submitted to us as originals, the conformity to the originals of all
documents submitted to us as copies and the authenticity of the originals of all documents submitted to us as copies. We have also assumed
the legal capacity of all natural persons, the genuineness of the signatures of persons signing all documents in connection with which
this opinion is rendered, the authority of such persons signing on behalf of the parties thereto other than the Company and the due authorization,
execution and delivery of all documents by the parties thereto other than the Company. We have not independently established or verified
any facts relevant to the opinion expressed herein, but have relied upon statements and representations of officers and other representatives
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Austin&#8239;&#8239;
Bay Area &#8239;Beijing &#8239;Boston &#8239;Brussels &#8239;Chicago &#8239;Dallas &#8239;Frankfurt &#8239;Hong&nbsp;Kong &#8239;Houston
 &#8239;London &#8239;Los&nbsp;Angeles &#8239;Miami &#8239;Munich &#8239;Paris &#8239;Riyadh Salt&nbsp;Lake&nbsp;City &#8239;Shanghai
 &#8239;Washington,&nbsp;D.C.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm255723d2_ex5-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AbbVie Inc.<BR>
 February&nbsp;14, 2025<BR>
 Page&nbsp;2 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with this opinion, we have also assumed
that (a)&nbsp;the Registration Statement, and any amendments thereto (including post-effective amendments), relating to the offered Debt
Securities will have become effective under the Act; (b)&nbsp;a prospectus supplement or term sheet (the &ldquo;<U>Prospectus Supplement</U>&rdquo;)
will have been prepared and filed with the Commission describing the Debt Securities offered thereby; (c)&nbsp;all offered Debt Securities
will be issued and sold in compliance with applicable federal and state securities laws and in the manner stated in the Registration Statement
and the appropriate Prospectus Supplement; (d)&nbsp;a definitive purchase, underwriting, sales agency or similar agreement with respect
to the offered Debt Securities will have been duly authorized and validly executed and delivered by the Company and the other parties
thereto; and (e)&nbsp;any applicable indenture and indenture trustee will have been qualified under the Trust Indenture Act of 1939, as
amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based upon and subject to the foregoing qualifications,
assumptions and limitations and the further limitations set forth below, and having regard for such legal considerations as we have deemed
relevant, we advise you that when the Debt Securities and the applicable indenture have been authorized by appropriate corporate authorization,
the applicable indenture has been duly executed by the parties thereto, and the Debt Securities have been executed, authenticated and
delivered in accordance with the applicable indenture against payment therefore, the Debt Securities will be validly issued, and the Debt
Securities will constitute binding obligations of the Company, in each case subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting creditors&rsquo; rights and to general equity principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We did not find it necessary for the purposes of
this opinion, and accordingly we do not purport to cover herein, the application of the securities or &ldquo;<U>Blue Sky</U>&rdquo; laws
of the various states. We undertake no responsibility to update or supplement this opinion in response to changes in law or future events
or other circumstances. The opinion expressed herein concerns only the effect of the law (excluding the principles of conflicts of law)
of the State of New York and the Delaware General Corporation Law, in each case as currently in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This opinion is being furnished in accordance with
the requirements of Item 601 of Regulation S-K promulgated under the Act, and no opinion is expressed herein as to any matter pertaining
to the contents of the Registration Statement, other than as to the specific issues addressed herein, and no opinion may be inferred or
implied beyond that expressly stated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This opinion is rendered solely for your benefit
and may not be used, circulated, quoted relied upon or otherwise referred to by any other person for any other purpose without our prior
written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have relied as to certain matters on information
obtained from public officials, officers of the Company and other sources believed by us to be responsible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm255723d2_ex5-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AbbVie Inc.<BR>
 February&nbsp;14, 2025<BR>
 Page&nbsp;3 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby consent to the filing of this opinion
with the Commission as Exhibit&nbsp;5.1 to the Registration Statement and to the reference to our firm and this opinion in the Registration
Statement in the section &ldquo;Legal Matters.&rdquo; <FONT STYLE="background-color: white">In giving this consent, we do not thereby
admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules&nbsp;and
regulations of the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%">Sincerely,</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>/s/ KIRKLAND&nbsp;&amp; ELLIS LLP</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>KIRKLAND&nbsp;&amp; ELLIS LLP</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm255723d2_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; color: #333333"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white; color: #333333"><B>Exhibit
23.1&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; color: #333333"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; color: #333333"><B>Consent
of Independent Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; background-color: white; color: #333333">We consent to the reference
to our firm under the caption &ldquo;Experts&rdquo; in the Registration Statement (Form S-3) and related Prospectus of AbbVie Inc. for
the registration of debt securities and to the incorporation by reference therein of our reports dated February 14, 2025, with respect
to the consolidated financial statements of AbbVie Inc.&nbsp;and subsidiaries, and the effectiveness of internal control over financial
reporting of AbbVie Inc. and subsidiaries, included in its Annual Report (Form 10-K) for the year ended December 31, 2024, filed with
the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">/s/ Ernst &amp; Young LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">Chicago, IL</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">February 14, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-25.1
<SEQUENCE>4
<FILENAME>tm255723d2_ex25-1.htm
<DESCRIPTION>EXHIBIT 25.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 25.1</B></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>securities
and exchange commission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;T-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Statement
of Eligibility Under</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>The
Trust Indenture Act of 1939 of a</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Corporation
Designated to Act as Trustee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Check if an Application to Determine Eligibility
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">a
Trustee Pursuant to Section&nbsp;305(b)(2)&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Trustee as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>91-1821036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">I.R.S. Employer Identification No.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">800 Nicollet Mall</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Minneapolis, Minnesota</P></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">55402</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Linda Garcia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">U.S. Bank Trust Company, National Association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">190 S. LaSalle Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chicago,&nbsp;IL 60603</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(312) 332-6781</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address and telephone number of agent for
service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Exact name of obligor as
specified in its charter)</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32-0375147</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of incorporation or organization)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer Identification No.)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1 North Waukegan Road</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">North Chicago,&nbsp;Illinois</P></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">60064</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Title of the Indenture
Securities)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM&nbsp;T-1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%"><B>Item 1.</B></TD>
    <TD STYLE="width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL INFORMATION<I>.</I></FONT>
    Furnish the following information as to the Trustee.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a)</TD><TD><I>Name and address of each examining or supervising authority to
                                            which it is subject.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Comptroller of the Currency</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Washington, D.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify"><I>Whether it is authorized
                                            to exercise corporate trust powers.</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Yes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 2. </B></FONT></TD>
  <TD STYLE="text-align: left; width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AFFILIATIONS
  WITH THE OBLIGOR. </B></FONT> <I>If the obligor is an affiliate of the Trustee, describe each such affiliation.</I></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in">&nbsp;None</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Items 3-15 </B></FONT></TD>
  <TD STYLE="text-align: justify; width: 91%"><I>Items 3-15 are not applicable because to the best of the Trustee's knowledge, the obligor
  is not in default under any Indenture for which the Trustee acts as Trustee.</I></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 16. </B></FONT></TD>
  <TD STYLE="text-align: left; width: 91%"><B>LIST OF EXHIBITS:</B> <I>List below all exhibits filed as a part of this statement of eligibility.</I></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 9%">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 3%">1.</TD>
  <TD STYLE="text-align: left; width: 88%">A copy of the Articles of Association of the Trustee as now in effect, attached as Exhibit&nbsp;1.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 9%">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 3%">2.</TD>
  <TD STYLE="text-align: left; width: 88%">A copy of the certificate of authority of the Trustee to commence business, attached as Exhibit&nbsp;2.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9%"></TD><TD STYLE="width: 3%">3.</TD><TD STYLE="width: 88%">A copy of the authorization of the Trustee to exercise
                                            corporate trust powers, included as Exhibit&nbsp;2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9%"></TD><TD STYLE="width: 3%">4.</TD><TD STYLE="width: 88%">A copy of the existing bylaws of the Trustee, attached
                                            as Exhibit&nbsp;4.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9%"></TD><TD STYLE="width: 3%">5.</TD><TD STYLE="width: 88%">A copy of each Indenture referred to in Item 4. Not applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9%"></TD><TD STYLE="width: 3%">6.</TD><TD STYLE="width: 88%">The consent of the Trustee required by Section&nbsp;321(b)&nbsp;of
                                            the Trust Indenture Act of 1939, attached as Exhibit&nbsp;6.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9%"></TD><TD STYLE="width: 3%">7.</TD><TD STYLE="text-align: justify; width: 88%">Report of Condition of the Trustee as of September&nbsp;30,
                                            2024, published pursuant to law or the requirements of its supervising or examining authority,
                                            attached as Exhibit&nbsp;7.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Trust Indenture
Act of 1939, as amended, the Trustee, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association organized and existing
under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned,
thereunto duly authorized, all in the City of Chicago, State of Illinois on the 14th of February, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION</TD></TR>
                                                                                                                                      <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                      <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%; text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/
                                            Linda Garcia</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Linda Garcia</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Vice President</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;1</U></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLES OF ASSOCIATION<BR>
OF</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U. S. BANK TRUST COMPANY,
NATIONAL ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purpose of organizing an association
(the &ldquo;Association&rdquo;) to perform any lawful activities of national banks, the undersigned enter into the following Articles
of Association:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST.
</B></FONT>The title of this Association shall be U. S. Bank Trust Company, National Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECOND.
</B></FONT>The main office of the Association shall be in the city of Portland, county of Multnomah, state of Oregon. The business of
the Association will be limited to fiduciary powers and the support of activities incidental to the exercise of those powers. The Association
may not expand or alter its business beyond that stated in this article without the prior approval of the Comptroller of the Currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD.
</B></FONT>The board of directors of the Association shall consist of not less than five nor more than twenty-five persons, the exact
number to be fixed and determined from time to time by resolution of a majority of the full board of directors or by resolution of a
majority of the shareholders at any annual or special meeting thereof. Each director shall own common or preferred stock of the Association
or of a holding company owning the Association, with an aggregate par, fair market, or equity value of not less than $1,000, as of either
(i)&nbsp;the date of purchase, (ii)&nbsp;the date the person became a director, or (iii)&nbsp;the date of that person's most recent election
to the board of directors, whichever is more recent. Any combination of common or preferred stock of the Association or holding company
may be used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any vacancy in the board of directors may be
filled by action of a majority of the remaining directors between meetings of shareholders. The board of directors may increase the number
of directors up to the maximum permitted by law. Terms of directors, including directors selected to fill vacancies, shall expire at
the next regular meeting of shareholders at which directors are elected, unless the directors resign or are removed from office. Despite
the expiration of a director's term, the director shall continue to serve until his or her successor is elected and qualified or until
there is a decrease in the number of directors and his or her position is eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Honorary or advisory members of the board of
directors, without voting power or power of final decision in matters concerning the business of the Association, may be appointed by
resolution of a majority of the full board of directors, or by resolution of shareholders at any annual or special meeting. Honorary
or advisory directors shall not be counted to determined the number of directors of the Association or the presence of a quorum in connection
with any board action, and shall not be required to own qualifying shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOURTH.
</B></FONT>There shall be an annual meeting of the shareholders to elect directors and transact whatever other business may be brought
before the meeting. It shall be held at the main office or any other convenient place the board of directors may designate, on the day
of each year specified therefor in the Bylaws, or <FONT STYLE="font-size: 10pt">if that</FONT> day falls on a legal holiday in the state
in which the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Association
is located, on the next following banking day. If </FONT>no election is held on the day fixed or in the event of a legal holiday on the
following banking day, an election may be held on any subsequent day within 60 days of the day fixed, to be designated by the board of
directors, or, <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if </FONT>the directors fail to fix the day,
by shareholders representing two-thirds of the shares issued and outstanding. In all cases, at least 10 days&rsquo; advance notice of
the meeting shall be given to the shareholders by first-class mail.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In all elections of directors, the number of
votes each common shareholder may cast will be determined by multiplying the number of shares he or she owns by the number of directors
to be elected. Those votes may be cumulated and cast for a single candidate or may be distributed among two or more candidates in the
manner selected by the shareholder. On all other questions, each common shareholder shall be entitled to one vote for each share of stock
held by him or her.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A director may
resign at any time by delivering written notice to the board of directors, its chairperson, or to the Association, which resignation
shall be effective when the notice is delivered unless the notice specifies a later effective date.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
director may be removed by the shareholders at a meeting called to remove him or her, when notice of the meeting stating that the purpose
or one of the purposes is to remove </FONT><FONT STYLE="font-size: 10pt">him </FONT>or her is provided, <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
</FONT>there is a failure to fulfill one of the affirmative requirements for qualification, or for cause; provided, however, that a director
may not be removed <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if </FONT>the number of votes sufficient
to elect him or her under cumulative voting is voted against his or her removal.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIFTH.
</B></FONT>The authorized amount of capital stock of the Association shall be 1,000,000 shares of common stock of the par value of ten
dollars ($10) each; but said capital stock may be increased or decreased from time to time, according to the provisions of the laws of
the United States. The Association shall have only one class of capital stock.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No holder of shares of the capital stock of any
class of the Association shall have any preemptive or preferential right of subscription to any shares of any class of stock of the Association,
whether now or hereafter authorized, or to any obligations convertible into stock of the Association, issued, or sold, nor any right
of subscription to any thereof other than such, if any, as the board of directors, in its discretion, may from time to time determine
and at such price as the board of directors may from time to time fix.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfers
of the Association's stock are subject to the prior written approval of a federal depository institution regulatory agency. If no</FONT>
other agency approval is required, the approval of the Comptroller of the Currency must be obtained prior to any such transfers.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the Articles of
Association or required by law, (1)&nbsp;all matters requiring shareholder action, including amendments to the Articles of Association
must be approved by shareholders owning a majority voting interest in the outstanding voting stock, and (2)&nbsp;each shareholder shall
be entitled to one vote per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the Articles of
Association or required by law, all shares of voting stock shall be voted together as a class, on any matters requiring shareholder approval.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise provided in the Bylaws, the
record date for determining shareholders entitled to notice of and to vote at any meeting is the close of business on the day before
the first notice is mailed or otherwise sent to the shareholders, provided that in no event may a record date be more than 70 days before
the meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Association, at any time and from time to
time, may authorize and issue debt obligations, whether subordinated, without the approval of the shareholders. Obligations classified
as debt, whether subordinated, which may be issued by the Association without the approval of shareholders, do not carry voting rights
on any issue, including an increase or decrease in the aggregate number of the securities, or the exchange or reclassification of all
or part of securities into securities of another class or series.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIXTH.
</B></FONT>The board of directors shall appoint one of its members president of this Association and one of its members chairperson of
the board and shall have the power to appoint one or more vice presidents, a secretary who shall keep minutes of the directors' and shareholders'
meetings and be responsible for authenticating the records of the Association, and such other officers and employees as may be required
to transact the business of this Association. A duly appointed officer may appoint one or more officers or assistant officers if authorized
by the board of directors in accordance with the Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors shall have the power to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="width: 96%">Define
                                            the duties of the officers, employees, and agents of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; width: 96%">Delegate
                                            the performance of its duties, but not the responsibility for its duties, to the officers,
                                            employees, and agents of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify; width: 96%">Fix
                                            the compensation and enter employment contracts with its officers and employees upon reasonable
                                            terms and conditions consistent with applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="width: 96%">Dismiss
                                            officers and employees.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="width: 96%">Require
                                            bonds from officers and employees and to fix the penalty thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="text-align: justify; width: 96%">Ratify
                                            written policies authorized by the Association's management or committees of the board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="text-align: justify; width: 96%">Regulate
                                            the manner any increase or decrease of the capital of the Association shall be made; provided
                                            that nothing herein shall restrict the power of shareholders to increase or decrease the
                                            capital of the Association in accordance with law, and nothing shall raise or lower from
                                            two-thirds the percentage required for shareholder approval to increase or reduce the capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD STYLE="width: 96%">Manage
                                            and administer the business and affairs of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD STYLE="width: 96%">Adopt
                                            initial Bylaws, not inconsistent with law or the Articles of Association, for managing the
                                            business and regulating the affairs of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD><TD STYLE="width: 96%">Amend
                                            or repeal Bylaws, except to the extent that the Articles of Association reserve this power
                                            in whole or in part to the shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD><TD STYLE="width: 96%">Make
                                            contracts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD><TD STYLE="width: 96%">Generally
                                            perform all acts that are legal for a board of directors to perform.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVENTH.
</B></FONT>The board of directors shall have the power to change the location of the main office to any authorized branch within the
limits of the city of Portland, Oregon, without the approval of the shareholders, or with a vote of shareholders owning two-thirds of
the stock of the Association for a location outside such limits and upon receipt of a certificate of approval from the Comptroller of
the Currency, to any other location within or outside the limits of the city of Portland, Oregon, but not more than thirty miles beyond
such limits. The board of directors shall have the power to establish or change the location of any office or offices of the Association
to any other location permitted under applicable law, without approval of shareholders, subject to approval by the Comptroller of the
Currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EIGHTH.
</B></FONT>The corporate existence of this Association shall continue until termination according to the laws of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NINTH.
</B></FONT>The board of directors of the Association, or any shareholder owning, in the aggregate, not less than 25 percent of the stock
of the Association, may call a special meeting of shareholders at any time. Unless otherwise provided by the Bylaws or the laws of the
United States, or waived by shareholders, a notice of the time, place, and purpose of every annual and special meeting of the shareholders
shall be given by first-class mail, postage prepaid, mailed at least 10, and no more than 60, days prior to the date of the meeting to
each shareholder of record at his/her address as shown upon the books of the Association. Unless otherwise provided by the Bylaws, any
action requiring approval of shareholders must be effected at a duly called annual or special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TENTH.
</B></FONT>These Articles of Association may be amended at any regular or special meeting of the shareholders by the affirmative vote
of the holders of a majority of the stock of the Association, unless the vote of the holders of a greater amount of stock is required
by law, and in that case by the vote of the holders of such greater amount; provided, that the scope of the Association's activities
and services may not be expanded without the prior written approval of the Comptroller of the Currency. The Association's board of directors
may propose one or more amendments to the Articles of Association for submission to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
witness whereof, we have hereunto set our hands this </FONT><FONT STYLE="font-size: 10pt"><U>11<SUP>th</SUP></U></FONT> of June, 1997.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-size: 10pt">/s/ Jeffrey T. Grubb</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Jeffrey T. Grubb</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Robert D. Sznewajs</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Robert D. Sznewajs</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Dwight V. Board</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dwight V. Board</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ P. K. Chatterjee</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">P. K. Chatterjee</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Robert Lane</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Robert Lane</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Exhibit&nbsp;2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="tm255723d2_ex25-1img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;4</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. BANK TRUST COMPANY, NATIONAL
ASSOCIATION</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>AMENDED AND RESTATED BYLAWS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Meetings of Shareholders</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.1. <U>Annual
Meeting</U>. The annual meeting of the shareholders, for the election of directors and the transaction of any other proper business,
shall be held at a time and place as the Chairman or President may designate. Notice of such meeting shall be given not less than ten
(10)&nbsp;days or more than sixty (60) days prior to the date thereof, to each shareholder of the Association, unless the Office of the
Comptroller of the Currency (the &ldquo;OCC&rdquo;) determines that an emergency circumstance exists. In accordance with applicable law,
the sole shareholder of the Association is permitted to waive notice of the meeting. If, for any reason, an election of directors is
not made on the designated day, the election shall be held on some subsequent day, as soon thereafter as practicable, with prior notice
thereof. Failure to hold an annual meeting as required by these Bylaws shall not affect the validity of any corporate action or work
a forfeiture or dissolution of the Association.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.2. <U>Special
Meetings</U>. Except as otherwise specially provided by law, special meetings of the shareholders may be called for any purpose, at any
time by a majority of the board of directors (the &ldquo;Board&rdquo;), or by any shareholder or group of shareholders owning at least
ten percent of the outstanding stock.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Every such special meeting, unless otherwise
provided by law, shall be called upon not less than ten (10)&nbsp;days nor more than sixty (60) days prior notice stating the purpose
of the meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.3. <U>Nominations
for Directors</U>. Nominations for election to the Board may be made by the Board or by any shareholder.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.4. <U>Proxies</U>.
Shareholders may vote at any meeting of the shareholders by proxies duly authorized in writing. Proxies shall be valid only for one meeting
and any adjournments of such meeting and shall be filed with the records of the meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.5. <U>Record
Date</U>. The record date for determining shareholders entitled to notice and to vote at any meeting will be thirty days before the date
of such meeting, unless otherwise determined by the Board.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.6. <U>Quorum
and Voting</U>. A majority of the outstanding capital stock, represented in person or by proxy, shall constitute a quorum at any meeting
of shareholders, unless otherwise provided by law, but less than a quorum may adjourn any meeting, from time to time, and the meeting
may be held as adjourned without further notice. A majority of the votes cast shall decide every question or matter submitted to the
shareholders at any meeting, unless otherwise provided by law or by the Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.7. <U>Inspectors</U>.
The Board may, and in the event of its failure so to do, the Chairman of the Board may appoint Inspectors of Election who shall determine
the presence of quorum, the validity of proxies, and the results of all elections and all other matters voted upon by shareholders at
all annual and special meetings of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.8. <U>Waiver
and Consent</U>. The shareholders may act without notice or a meeting by a unanimous written consent by all shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.9. <U>Remote
Meetings</U>. The Board shall have the right to determine that a shareholder meeting not be held at a place, but instead be held solely
by means of remote communication in the manner and to the extent permitted by the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;II</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.1. <U>Board
of Directors</U>. The Board shall have the power to manage and administer the business and affairs of the Association. Except as expressly
limited by law, all corporate powers of the Association shall be vested in and may be exercised by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.2. <U>Term
of Office</U>. The directors of this Association shall hold office for one year and until their successors are duly elected and qualified,
or until their earlier resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.3. <U>Powers</U>.
In addition to the foregoing, the Board shall have and may exercise all of the powers granted to or conferred upon it by the Articles
of Association, the Bylaws and by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.4. <U>Number</U>.
As provided in the Articles of Association, the Board of this Association shall consist of no less than five nor more than twenty-five
members, unless the OCC has exempted the Association from the twenty-five- member limit. The Board shall consist of a number of members
to be fixed and determined from time to time by resolution of the Board or the shareholders at any meeting thereof, in accordance with
the Articles of Association. Between meetings of the shareholders held for the purpose of electing directors, the Board by a majority
vote of the full Board may increase the size of the Board but not to more than a total of twenty-five directors, and fill any vacancy
so created in the Board; provided that the Board may increase the number of directors only by up to two directors, when the number of
directors last elected by shareholders was fifteen or fewer, and by up to four directors, when the number of directors last elected by
shareholders was sixteen or more. Each director shall own a qualifying equity interest in the Association or a company that has control
of the Association in each case as required by applicable law. Each director shall own such qualifying equity interest in his or her
own right and meet any minimum threshold ownership required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.5. <U>Organization
Meeting</U>. The newly elected Board shall meet for the purpose of organizing the new Board and electing and appointing such officers
of the Association as may be appropriate. Such meeting shall be held on the day of the election or as soon thereafter as practicable,
and, in any event, within thirty days thereafter, at such time and place as the Chairman or President may designate. If, at the time
fixed for such meeting, there shall not be a quorum present, the directors present may adjourn the meeting until a quorum is obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.6. <U>Regular
Meetings</U>. The regular meetings of the Board shall be held, without notice, as the Chairman or President may designate and deem suitable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.7. <U>Special
Meetings</U>. Special meetings of the Board may be called at any time, at any place and for any purpose by the Chairman of the Board
or the President of the Association, or upon the request of a majority of the entire Board. Notice of every special meeting of the Board
shall be given to the directors at their usual places of business, or at such other addresses as shall have been furnished by them for
the purpose. Such notice shall be given at least twelve hours (three hours if meeting is to be conducted by conference telephone) before
the meeting by telephone or by being personally delivered, mailed, or electronically delivered. Such notice need not include a statement
of the business to be transacted at, or the purpose of, any such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.8. <U>Quorum
and Necessary Vote</U>. A majority of the directors shall constitute a quorum at any meeting of the Board, except when otherwise provided
by law; but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice.
Unless otherwise provided by law or the Articles or Bylaws of this Association, once a quorum is established, any act by a majority of
those directors present and voting shall be the act of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.9. <U>Written
Consent</U>. Except as otherwise required by applicable laws and regulations, the Board may act without a meeting by a unanimous written
consent by all directors, to be filed with the Secretary of the Association as part of the corporate records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.10. <U>Remote
Meetings</U>. Members of the Board, or of any committee thereof, may participate in a meeting of such Board or committee by means of
conference telephone, video or similar communications equipment by means of which all persons participating in the meeting can hear each
other and such participation shall constitute presence in person at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.11. <U>Vacancies</U>.
When any vacancy occurs among the directors, the remaining members of the Board may appoint a director to fill such vacancy at any regular
meeting of the Board, or at a special meeting called for that purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;III</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Committees</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.1. <U>Advisory
Board of Directors</U>. The Board may appoint persons, who need not be directors, to serve as advisory directors on an advisory board
of directors established with respect to the business affairs of either this Association alone or the business affairs of a group of
affiliated organizations of which this Association is one. Advisory directors shall have such powers and duties as may be determined
by the Board, provided, that the Board's responsibility for the business and affairs of this Association shall in no respect be delegated
or diminished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.2. <U>Trust
Audit Committee</U>. At least once during each calendar year, the Association shall arrange for a suitable audit (by internal or external
auditors) of all significant fiduciary activities under the direction of its trust audit committee, a function that will be fulfilled
by the Audit Committee of the financial holding company that is the ultimate parent of this Association. The Association shall note the
results of the audit (including significant actions taken as a result of the audit) in the minutes of the Board. In lieu of annual audits,
the Association may adopt a continuous audit system in accordance with 12 C.F.R. &sect; 9.9(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee of the financial holding
company that is the ultimate parent of this Association, fulfilling the function of the trust audit committee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Must
not include any officers of the Association or an affiliate who participate significantly in the administration of the Association&rsquo;s
fiduciary activities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Must
consist of a majority of members who are not also members of any committee to which the Board has delegated power to manage and control
the fiduciary activities of the Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.3. <U>Executive
Committee</U>. The Board may appoint an Executive Committee which shall consist of at least three directors and which shall have, and
may exercise, to the extent permitted by applicable law, all the powers of the Board between meetings of the Board or otherwise when
the Board is not meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.4. <U>Trust
Management Committee</U>. The Board of this Association shall appoint a Trust Management Committee to provide oversight of the fiduciary
activities of the Association. The Trust Management Committee shall determine policies governing fiduciary activities. The Trust Management
Committee or such sub-committees, officers or others as may be duly designated by the Trust Management Committee shall oversee the processes
related to fiduciary activities to assure conformity with fiduciary policies it establishes, including ratifying the acceptance and the
closing out or relinquishment of all trusts. The Trust Management Committee will provide regular reports of its activities to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.5. <U>Other
Committees</U>. The Board may appoint, from time to time, committees of one or more persons who need not be directors, for such purposes
and with such powers as the Board may determine; however, the Board will not delegate to any committee any powers or responsibilities
that it is prohibited from delegating under any law or regulation. In addition, either the Chairman or the President may appoint, from
time to time, committees of one or more officers, employees, agents or other persons, for such purposes and with such powers as either
the Chairman or the President deems appropriate and proper. Whether appointed by the Board, the Chairman, or the President, any such
committee shall at all times be subject to the direction and control of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.6. <U>Meetings,
Minutes and Rules</U>. An advisory board of directors and/or committee shall meet as necessary in consideration of the purpose of the
advisory board of directors or committee, and shall maintain minutes in sufficient detail to indicate actions taken or recommendations
made; unless required by the members, discussions, votes or other specific details need not be reported. An advisory board of directors
or a committee may, in consideration of its purpose, adopt its own rules&nbsp;for the exercise of any of its functions or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;IV</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Officers</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.1. <U>Chairman
of the Board</U>. The Board may appoint one of its members to be Chairman of the Board to serve at the pleasure of the Board. The Chairman
shall supervise the carrying out of the policies adopted or approved by the Board; shall have general executive powers, as well as the
specific powers conferred by these Bylaws; and shall also have and may exercise such powers and duties as from time to time may be conferred
upon or assigned by the Board.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.2. <U>President</U>.
The Board may appoint one of its members to be President of the Association. In the absence of the Chairman, the President shall preside
at any meeting of the Board. The President shall have general executive powers, and shall have and may exercise any and all other powers
and duties pertaining by law, regulation or practice, to the office of President, or imposed by these Bylaws. The President shall also
have and may exercise such powers and duties as from time to time may be conferred or assigned by the Board.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.3. <U>Vice
President</U>. The Board may appoint one or more Vice Presidents who shall have such powers and duties as may be assigned by the Board
and to perform the duties of the President on those occasions when the President is absent, including presiding at any meeting of the
Board in the absence of both the Chairman and President.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.4. <U>Secretary</U>.
The Board shall appoint a Secretary, or other designated officer who shall be Secretary of the Board and of the Association, and shall
keep accurate minutes of all meetings. The Secretary shall attend to the giving of all notices required by these Bylaws to be given;
shall be custodian of the corporate seal, records, documents and papers of the Association; shall provide for the keeping of proper records
of all transactions of the Association; shall, upon request, authenticate any records of the Association; shall have and may exercise
any and all other powers and duties pertaining by law, regulation or practice, to the Secretary, or imposed by these Bylaws; and shall
also perform such other duties as may be assigned from time to time by the Board. The Board may appoint one or more Assistant Secretaries
with such powers and duties as the Board, the President or the Secretary shall from time to time determine.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.5. <U>Other
Officers</U>. The Board may appoint, and may authorize the Chairman, the President or any other officer to appoint, any officer as from
time to time may appear to the Board, the Chairman, the President or such other officer to be required or desirable to transact the business
of the Association. Such officers shall exercise such powers and perform such duties as pertain to their several offices, or as may be
conferred upon or assigned to them by these Bylaws, the Board, the Chairman, the President or such other authorized officer. Any person
may hold two offices.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.6. <U>Tenure
of Office</U>. The Chairman or the President and all other officers shall hold office until their respective successors are elected and
qualified or until their earlier death, resignation, retirement, disqualification or removal from office, subject to the right of the
Board or authorized officer to discharge any officer at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;V</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Stock</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.1. The Board
may authorize the issuance of stock either in certificated or in uncertificated form. Certificates for shares of stock shall be in such
form as the Board may from time to time prescribe. If the Board issues certificated stock, the certificate shall be signed by the President,
Secretary or any other such officer as the Board so determines. Shares of stock shall be transferable on the books of the Association,
and a transfer book shall be kept in which all transfers of stock shall be recorded. Every person becoming a shareholder by such transfer
shall, in proportion to such person's shares, succeed to all rights of the prior holder of such shares. Each certificate of stock shall
recite on its face that the stock represented thereby is transferable only upon the books of the Association properly endorsed. The Board
may impose conditions upon the transfer of the stock reasonably calculated to simplify the work of the Association for stock transfers,
voting at shareholder meetings, and related matters, and to protect it against fraudulent transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;VI</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Corporate Seal</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;6.1. The Association
shall have no corporate seal; provided, however, that if the use of a seal is required by, or is otherwise convenient or advisable pursuant
to, the laws or regulations of any jurisdiction, the following seal may be used, and the Chairman, the President, the Secretary and any
Assistant Secretary shall have the authority to affix such seal:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;VII</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Miscellaneous Provisions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.1. <U>Execution
of Instruments</U>. All agreements, checks, drafts, orders, indentures, notes, mortgages, deeds, conveyances, transfers, endorsements,
assignments, certificates, declarations, receipts, discharges, releases, satisfactions, settlements, petitions, schedules, accounts,
affidavits, bonds, undertakings, guarantees, proxies and other instruments or documents may be signed, countersigned, executed, acknowledged,
endorsed, verified, delivered or accepted on behalf of the Association, whether in a fiduciary capacity or otherwise, by any officer
of the Association, or such employee or agent as may be designated from time to time by the Board by resolution, or by the Chairman or
the President by written instrument, which resolution or instrument shall be certified as in effect by the Secretary or an Assistant
Secretary of the Association. The provisions of this section are supplementary to any other provision of the Articles of Association
or Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.2. <U>Records</U>.
The Articles of Association, the Bylaws as revised or amended from time to time and the proceedings of all meetings of the shareholders,
the Board, and standing committees of the Board, shall be recorded in appropriate minute books provided for the purpose. The minutes
of each meeting shall be signed by the Secretary, or other officer appointed to act as Secretary of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.3. <U>Trust
Files</U>. There shall be maintained in the Association files all fiduciary records necessary to assure that its fiduciary responsibilities
have been properly undertaken and discharged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.4. <U>Trust
Investments</U>. Funds held in a fiduciary capacity shall be invested according to the instrument establishing the fiduciary relationship
and according to law. Where such instrument does not specify the character and class of investments to be made and does not vest in the
Association a discretion in the matter, funds held pursuant to such instrument shall be invested in investments in which corporate fiduciaries
may invest under law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.5. <U>Notice</U>.
Whenever notice is required by the Articles of Association, the Bylaws or law, such notice shall be by mail, postage prepaid, e- mail,
in person, or by any other means by which such notice can reasonably be expected to be received, using the address of the person to receive
such notice, or such other personal data, as may appear on the records of the Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except where specified otherwise in these Bylaws,
prior notice shall be proper if given not more than 30 days nor less than 10 days prior to the event for which notice is given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;VIII</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Indemnification</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.1. The Association
shall indemnify such persons for such liabilities in such manner under such circumstances and to such extent as permitted by Section&nbsp;145
of the Delaware General Corporation Law, as now enacted or hereafter amended. The Board may authorize the purchase and maintenance of
insurance and/or the execution of individual agreements for the purpose of such indemnification, and the Association shall advance all
reasonable costs and expenses (including attorneys&rsquo; fees) incurred in defending any action, suit or proceeding to all persons entitled
to indemnification under this Section&nbsp;8.1. Such insurance shall be consistent with the requirements of 12 C.F.R. &sect; 7.2014 and
shall exclude coverage of liability for a formal order assessing civil money penalties against an institution-affiliated party, as defined
at 12 U.S.C. &sect; 1813(u).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.2. Notwithstanding
Section&nbsp;8.1, however, (a)&nbsp;any indemnification payments to an institution-affiliated party, as defined at 12 U.S.C. &sect; 1813(u),
for an administrative proceeding or civil action initiated by a federal banking agency, shall be reasonable and consistent with the requirements
of 12 U.S.C. &sect; 1828(k)&nbsp;and the implementing regulations thereunder; and (b)&nbsp;any indemnification payments and advancement
of costs and expenses to an institution-affiliated party, as defined at 12 U.S.C. &sect; 1813(u), in cases involving an administrative
proceeding or civil action not initiated by a federal banking agency, shall be in accordance with Delaware General Corporation Law and
consistent with safe and sound banking practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;IX</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Bylaws: Interpretation and Amendment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.1. These Bylaws
shall be interpreted in accordance with and subject to appropriate provisions of law, and may be added to, altered, amended, or repealed,
at any regular or special meeting of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.2. A copy
of the Bylaws and all amendments shall at all times be kept in a convenient place at the principal office of the Association, and shall
be open for inspection to all shareholders during Association hours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;X</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Miscellaneous Provisions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.1. <U>Fiscal
Year</U>. The fiscal year of the Association shall begin on the first day of January&nbsp;in each year and shall end on the thirty-first
day of December&nbsp;following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.2. <U>Governing
Law</U>. This Association designates the Delaware General Corporation Law, as amended from time to time, as the governing law for its
corporate governance procedures, to the extent not inconsistent with Federal banking statutes and regulations or bank safety and soundness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">***</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">(February&nbsp;8, 2021)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Exhibit&nbsp;6</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with Section&nbsp;321(b)&nbsp;of
the Trust Indenture Act of 1939, the undersigned, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION hereby consents that reports of examination
of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and
Exchange Commission upon its request therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;14, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%; text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/
                                            Linda Garcia</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Linda Garcia</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Vice President</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;7</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U.S. Bank Trust Company, National Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Statement of Financial Condition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>as of 9/30/2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($000&rsquo;s)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><B>9/30/2024</B></TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
  <TD STYLE="padding-left: 0.125in; width: 87%; font-size: 10pt; text-align: left">Cash and Balances Due From Depository Institutions</TD>
  <TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
  <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$&nbsp;</TD>
  <TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,551,827<BR></TD>
  <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,568</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Federal Funds</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Loans &amp; Lease Financing Receivables</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Fixed Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,070</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Intangible Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">576,760</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; padding-bottom: 1pt; font-size: 10pt; text-align: left">Other Assets</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">153,717</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; font-weight: bold; text-align: left">Total Assets</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>2,287,942</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Deposits</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Fed Funds</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Treasury Demand Notes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Trading Liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Other Borrowed Money</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Acceptances</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Subordinated Notes and Debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; padding-bottom: 1pt; font-size: 10pt; text-align: left">Other Liabilities</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">215,240</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; font-weight: bold; text-align: left">Total Liabilities</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">215,240</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold">Equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Common and Preferred Stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">200</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Surplus</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,171,635</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Undivided Profits</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">900,867</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; padding-bottom: 1pt; font-size: 10pt; text-align: left">Minority Interest in Subsidiaries</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; font-size: 10pt; font-weight: bold; text-align: left">Total Equity Capital</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>2,072,702</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Total Liabilities and Equity Capital</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>2,287,942</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>tm255723d1_ex-filingfees.htm
<DESCRIPTION>FILING FEE IXBRL
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-204">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-205">S-3ASR</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-206">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-207">0001551152</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-208">AbbVie Inc.</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-02-06</xbrli:startDate>
              <xbrli:endDate>2025-02-06</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-02-06</xbrli:startDate>
              <xbrli:endDate>2025-02-06</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-233">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-234">AbbVie Inc.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word">
            <p style="margin: 0pt; text-align: center;">
              <b>Table 1: Newly Registered and Carry Forward Securities</b>
            </p>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-235">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-236">Debt</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-237">Debt Securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-238">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-239">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-240">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-241">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-242">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-243">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-244">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-245">The Registrant is relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all registration fees. In connection with the securities offered hereby, the Registrant will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The Registrant will calculate the registration fee applicable to an offer of securities pursuant to this Registration Statement based on the fee payment rate in effect on the date of such fee payment.

An indeterminate amount of securities to be offered at indeterminate prices is being registered pursuant to this Registration Statement.
</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm255723d2_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm255723d2_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  = 0\# 2(  A$! Q$!_\0
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MW\[.O(AB!PL:^G0$_P#UJP_!"C_AH#QPV!D0H ?^^* /8*YO5/'6@:+XDM=
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MP\+C1M/#0X\H_94S'@Y&WCCDD\=ZE.CZ8=0&H'3K0WH.1<&!?,SC'WL9Z<4
M>2Z5='X.^-GT*[\QO"^LR^98SDY%M)T*M[<C/X'UJM<VUGJO[2U_872K+;SZ
M68)$/0YA!(_(YKVB\L+/4(?)O;2"YBSG9-&'7/T-0IHNE17PO8],LTNQTG6!
M1(.,?>QGIQ0!Y-X,NW^%?C&X\%:Q<,=(OF\_2KN3[N2<%#Z$G]1[UFZ3XMT7
MPM\=/&5UJ]X+>&=5B1]I8%ALR./H:]OO=,L-25%OK*VNE0Y43Q*^T^V1Q567
MPSH$\SS3:'ILDKDLSO:1DL3U))')H \[\7_%K1[[P=K$?ARYEGO&5+2.54*
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BUZ5ZX!@8'2JECI>GZ8KK86%K:!R"X@A6/=]<#FK= '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>lg_abbvie-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_abbvie-4c.jpg
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M%!04%!04%!04%/_  !$( 'D"M ,!$0 "$0$#$0'_Q "Y  $  @,! 0$!
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M%<NO=7+7K?VYN.Q<6Y<T4S;ZTFP4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * XCU$[^M[+VN#%M<-NXY;> XJ$Q()$=AEH@*>>"
M"%*U)Y4(!&O'CY/&=BXWW7QT1'O7N1>9&W&>M[<F#=VG<H@6^ZV1:QZ3&CLJ
MBR$-D\2RL+4-0.Y:3KXNVK*?M\&N%4R)'*E7B3QLEYM^16:WW^TN^>MESCM3
M(;NFG,R^@.()'<=#Q%4,HN+:?@62=54]]8GHH!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0$#NN[]^L7^:5_I+E7WMO0_4K<O
MJ1%&K4A%KVQ?\&\&^987]BFN4R?RR]2ZM="]#H-1S:* 4 H!0"@% * 4 H!0
M"@% * AWU[?Y9@WX^Y?T(U7'MNLO@0,O1$)*NRO+,>DC^ V-?C)_Z<_7,YOY
MG\/D6^/T([=4(D"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0$"^NUE].?XU(4#Z,Y9RVVK3@5MRG2L ^$!2:OO;>A^I6Y?4B*E6
MI"+6MA&7H^S.#MR$E#AM$982KMY'$\Z#[:2#7*Y/Y9>I=6>A'1:C&T4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"!W7=^_6
M+_-*_P!)<J^]MZ'ZE;E]2(HU:D(M>V+_ (-X-\RPO[%-<ID_EEZEU:Z%Z'0:
MCFT4 H!0"@% * 4 H!0"@% * 4!#OKV_RS!OQ]R_H1JN/;=9? @9>B(25=E>
M68])'\!L:_&3_P!.?KF<W\S^'R+?'Z$=NJ$2!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H#G^[.S^);PV-FT9*EUF3#4IVVW.*0
MF1&<6 %:<P(4A6@YT*&AT'80")%B_*TZHU7+:FJ,XIC70SAEKN[,_(<BF7NW
M,K#GQ:EA$-#O*=0EUQ+CBBD]_)RGQBIL_<9-42H1XXJ3XLE0RRS'9;CQVTM,
M-)#;32 $H0A(T"4@<  !H!5433[H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0&H7W=7;7&5%N^Y9:H3Z>!8<F,EX?^6E17_-6Z-F<M$S6[D5JS3I75)L/$
M)2O+VG% Z$,Q9KH_E0P1_/6Y8=Y_28??AN>?UL-A?I5_@9_Y"O>RO;?(\[B&
MX];#87Z5?X&?^0IV5[;Y#N(;CUL-A?I5_@9_Y"G97MOD.XAN!U7["D@?M5IJ
M=-3!GZ?H].RO;?(=Q#<S-MZBMDKJM+<7-;>A2B /2BY#&I\<A#8K!XMU?2S)
M7H/Q.A6R\6B]QQ+LT^-<8ATT?B/-R&^/9Y394*CN+6J-J:>A[:Q/10"@% *
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M.&;ABEYB7B(D@.+AO(=*">P+2#S(/#L4!4:=N4'22H;8R4M#.5@9"@% * 4
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M!] 6[*6 XU *AKYJ-KJ.8=BG>T]VB>WG,G+=QT7"):V;"AQ>IWNH!)% * 4
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M,%C5/IKR.9YT>-MM24C\9X0*J?<+U$H+Q)V+"KYB=%418B@% * 4 H!0"@%
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M]NR>P2!*L]T93(BO#@2E7 I4.Y22"E23Q"@17+3@X-IZHN8R4E5&6K R% *
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M@UTR*@[;TBO--;\8\EP@%UFX-MZ_7^A/*_X U!SOPOX$C'ZT675S1;B@% *
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MJ;ST[V1=_P!ZL-A)1SI8N")[G#4!$!*I))\7WNM&5+EM2]#9959HM0KEBY%
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M.98^Y#AJB18N<DN.C++4J2M(6@A25#5*AQ!![Q7-%N?V@% * 4 H!0"@% *
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MI!C7*W/HE6^8TA^+)94%MN-.I"D+2H<""#J#7+--.C+A.IZ*\/10"@% * 4
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M"E/C+@B)=R%'@N+*_P"_7Z\91>9N07^6Y/O%P=+\N6Z=5K6>'=H    E(X)
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MGEG3B?ZM9Y^X<W;7/7\.=OBN*+2W?C+7@SO?;Q'94 DB@% * 4 H!0"@% *
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M=;[_ ,*,D_\ ;C^FFI.-^1&J[TLBST4_OM=?_:__ 'JT]PZ$0\;J)UU1%B*
F4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm255723d2_ex25-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm255723d2_ex25-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,3 E@# 2(  A$! Q$!_\0
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M.V61G*D=" 6-4-?\"O?V6E:5;K)+%%<F>XO)91N(9LN,9R<UV'DZA_S]1_\
M?%'DZA_S]1_]\4 7554144 *HP .PI:H^3J'_/U'_P!\4>3J'_/U'_WQ0!>H
MJCY.H?\ /U'_ -\4>3J'_/U'_P!\4 7J*H^3J'_/U'_WQ1Y.H?\ /U'_ -\4
M 7J*H^3J'_/U'_WQ1Y.H?\_4?_?% %ZBJ/DZA_S]1_\ ?%'DZA_S]1_]\4 7
MJ*H^3J'_ #]1_P#?%'DZA_S]1_\ ?% %ZBJ/DZA_S]1_]\4>3J'_ #]1_P#?
M% %ZBJ/DZA_S]1_]\4>3J'_/U'_WQ0!>HJCY.H?\_4?_ 'Q1Y.H?\_4?_?%
M%ZBJ/DZA_P _4?\ WQ1Y.H?\_4?_ 'Q0!>HJCY.H?\_4?_?%'DZA_P _4?\
MWQ0!>HJCY.H?\_4?_?%'DZA_S]1_]\4 7J*H^3J'_/U'_P!\4>3J'_/U'_WQ
M0!>HJCY.H?\ /U'_ -\4>3J'_/U'_P!\4 7J*H^3J'_/U'_WQ5T9P,\F@!:*
M** "BBB@ HHHH **** "N7O/A]X>U'69=4O+5IIY#E@[DJ?PKJ**J,Y1^%V$
MTGN06EG;6%NL%I!'#$O1$7 %3T45-[C"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *YF\\:65C8R7,T$P,=VUJ\8QN&
MUL%O]T $_2NFKCKCPG->>*+^6<(=+N(6(&>?,9-C<?0DT ;9\0V$379NYX[6
M&WD$7G3R!5=L=B3^%2OKVD1O CZI9JUP 809U_> ]-O/-<HF@Z]%IFFB2)9;
MA)))+@12*KAFSR&)Z<]JS8O!^N6^F00Q6JK=" 0F5;@%,CH74GYE_,T =K9^
M*-+N[Z:Q:ZAANH[AX%ADE4.Y4XR!G/-.C\3:3MB%QJ%I;RR$!8I+A,DGIWK%
M_P"$;O?L<P,4?GOK$=YN!',:S*Y/_?(/%4(_"&H#2M9A>",SW5@8(3N'WMN.
MO;F@#L;C6]*M;Q;2XU&TBN7("Q/,H8DG X)SSFJ=EXKT:\M[RX%_;QPVDQBE
M=Y5 !!QG.>A[5Q>IB>+4Y=*CMUGEGU2VGWD?.H$JL>.I  /(XQWK8;0-4BN6
MG2TCE%OJ<EY'&74"97!&/8C.>>XH Z6;Q#HUND3S:K91I*N^-GG4!U]1SR*T
M58,H92"#R".]<+;>$[X27LTT,1:YL+F-4W B-Y&!"CVX/-=)I$EW!(FG36Q6
M."W4^=G(+?W: *5QXJDANK]8])N9K:P.)YT9/E&,DA<[C@#L*?)XJ\V27^S=
M-N=0B@&9I(2H"^PR1N/L,FLZ:PUV"[UR&TL$>/46/EW#RJ%0$$9(SGC/I2V&
MEZWX;6[M=-M8KN&X8R)(T@7RG/7<#U&?3- '07&LV]OHO]J%9&B*J50*=S%B
M JX]22!69_PE\:B2&73[B/4%E2);,E2SEP2,$'&,*QZ\8JY=IK%OX:,=J4N=
M4"*NXX4$Y&3SQP,D?2L"+0]16"WNX]/=;^UNQ<MY\Z,USE&0\@G& YQF@#3;
MQ<C1(+;3KF>ZVNTMNI4-$$QNR2<<9' ZYJ;_ (2W3C-I<2"9GU%L18C.!\K-
MR>@^Z:PI=(UY8?(^R,]M=RR7%W'#.BMEL8CR2/EZYQ6Y>:7/<QZ%Y%JL"VER
M)9(MP^1?+=<<=>6'2@!K>*X5NROV2<V2W M6O.-@D)P!CKC) SC'-=#7"ZCX
M3O;S6&CCB:.Q>\CNRRW'[O*L&^Y_>.T#IBNZ' Q0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% ";5SG SZXI:** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X/XC
M^*+_ $5M&TK3'$-UJUVEMYY&?*4G!(]ZU4\-7]NL$<>OZC)!M<7!EG)D;*$
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M)M*\%>&;[4-6OK;4)KM8;C[%*3OC;)Z)G+8 Z9KKIOAJM[KVJ:C?ZI]H@U&
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M$R,;B-WS' %2W/@RWU'P_8:;J=P+F>Q*F&Z$00@KTXSZ8'6KTYK]-/NO_3_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN/8U"_B'Q%;>'9+]O%M@$F:'"QW+3RQN3\ZG<B^7U'RG)X-6UK;^M[$J7?\
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M:[EAMWMY;@J;<?/AEX.0>>N.G?M5D^(%_"WDMH0>?^TVT_\ =7(,:G8'5B2
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MA4$@LX+@<$$<$]*Q](^)VGV&@Z4FL2S7%[+ LEQ*AC&S<Q )#,">G10:%J[
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MOIXO5B:TODMGE:&.^:-?)D=205'S;NH(Y4 TV+QWITNE2:C]CO5@4 IN6/\
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M/%5NF_ZZ_K<BR5H_ULOTL<U<> M1N+"UM_[;LHGM[B*;?#I83?Y;!@& DZY
MYS^%-C^'^HK.]VWB&/[:+TWL$JV.%C<@A@5\P[@02.HKKWU?3(XS(^HVBH"
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M:;F93$[ABN#W(XJ_'J>GS2&.*^MGD"[BJRJ2!ZXSTJ[ZW_K7_AQ))K3^K?\
M#&+!X:O;'6[F[L=6$-E=R^;/:M;;F+=]K[AMS]#52U\$SVKQVXU<-ID$WGV]
MJUM\R..5R^[E0<'&!TZUL7OB?1K'2Y]1?4;:2V@^^T4JMSV'7K5F#44N)B8Y
M+5K7RA()%GRWXKC 'OFHLK6[?\/_ ,,-V>_7_AO^'.,M?AWJD#Z<)/$<,D-E
M/),$&G;2^]65AGS3CACVJU9> [ZRGT)EUU'BTEV98VL_]8"I7&=_'#'UKK(M
M4T^>!YX;^UDA0X:1)E*J?<@\4#5-/:"6<7]J88CB203+M3ZG/%4M/D)Q3.=7
MP7*+EXCJN[26N5NOL9@^82*P88DW?=W '&WMUJYX:\.76A3:D]QJ*7:WLYG"
MK;^5L)ZC.XY_2DU+Q7%9ZEHUM:P"\M]3G,(NHIE*1D*6[9R>/_KUT5"5EIZ?
ME_P!O?\ '\_^"<A;^"I[>18%U8'2XI_M$-J;;YDDZC+[N5!YQ@=.M7_"^@7V
M@QW<=WJD5ZL\QF79:^44)Z_QMGMZ5T%%"TV_K^K(&DW?^OZU84444#"BBB@
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M-C:K,);!Q'*9$V@D^G<]*T(KAI+F:(V\R+'C$CXVOG^[@YX]P*J^O-WU^_\
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MKTL>/WFA:I+/K5Q%X1U+S;IK1H"SPDAHWRY_UG'''%/U?1=5OHM:6/PGJO\
MI4]K-%NEBY9"=Y_UOH2,5Z[!.TSRJUO+$(VVAI,8?W7!/'UQ4U-+;^NW^0['
MD5[:7<%CK$)T"\LDNKBV:U5O)Q(ZYR HDPQQV)&0#S73_#ZRAL(-2M7LY[>^
MDE$UPLUM'"#N&!M5'< ?*>"U=5J>E6.L6OV:_MUFAW!@"2"".X(((-&G:79:
M3;^190^7'[L6)^I))-$=$T^O]?U\A<NUCSJW\/:K80@GP^+BWM]3>>6W1D#7
M*,I *@D [2>C$=3Z5UOA329['3+Y9[<V\5U<-+#:.0?)0J!M.,CJ"<#CFNDH
MI)6CR_+\O\AVUO\ UU_S/'X_#NJVB:1:2>%YYX;749KB9H#%AU*L!P6&?O#'
MX].]9?"NMW5KI_VK2=6ALK>2Y22TMI(!+B1E*LH8E2  1U!':O::*?J/K?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7<P[\,*=M4_ZWB_T?WBE&Z:_K:2_5?<<]=>,]6@\91:?$+*:QDNC;;4B;<A
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M@$'[PD?# _3%+=OY":DDM?Z_KH8]_P",O$FG2_8&M]-GNX]0@M9;@!TC99"
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M^LL1JD45J;^34UOI+3S<1H BIM#[>3\N2<<DT+L^_P#E_P $J3=DUV_S_P"
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MC),P9XUO)+DLWJ7?G]*:V=P;=S ;Q[<WNM7,.G7NDP65K,(I3=PRE^3C<"&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFJZ2=6OIH[B^R;;S%_A13Q@=L]_7 JSXSECTF33=?9%*VDQBG8C/[J12"/\
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MALI;!AILC6EV(\3O*$(+D@ *1EL8YZ=JL>"Y[I]6\317-[/=+#? 1F9L[%*
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MQ0=,#(X%7J*!C41(T"(H5%& JC  IU%% !1110 4444 %%%% !1110 4444
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M?X" "PP.^:RK?XA7US=Z)?20RP:==+/YMN+8F1R@R-N>H^E)I1?*_P#AM_\
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M%@ZE<#!P,!C7H-%"T=T2XIK4\_U'P)J\TEP++5+1()=22_V30ECE7#XR".X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<_4U?L=3-U*8);.YMIE&6$D9V_@_0_A0!H4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 452U.ZO+2U$EEISW\NX#RDE2,X]<L0*R/[
M=\1?]"=<_P#@?;__ !5 '24UW6-&=V"JHR23@ 5SO]N^(O\ H3KG_P #[?\
M^*J.76->GC,<O@N=T.,JU];D'!S_ 'J -)99=:1A$7ALMV"XRK2_3T7WJ6_N
M[3P]HDMQY>V"W7A$'4D\#\2:RQKOB(# \'7./^OZW_\ BJ/[=\1?]"=<_P#@
M?;__ !5 "Z;IMSJ$G]J7KJ'N8P HR&BCZA%/;/5O7 KHHXUBC5$4*JC  KG?
M[=\1?]"=<_\ @?;_ /Q5-?Q!X@C1G?PA<!5&23?V_ _[ZH WKV\BL+.6YF.$
MC&?J>P^IK*TJPFN[S^VM2CVW+IM@@/\ RP3K_P!]'O\ @*YW^T=<UV]M-43P
M[=36$()BMQ=Q(#)D@LV6^8>G;K6W_;OB+_H3KG_P/M__ (J@#6U*_FL?)\FP
MGN_,8J?*_@/;/H/>J<NGW^K*HOY3:VX.?(MY"&8>CL/QX'!JK_;OB+_H3KG_
M ,#[?_XJC^W?$7_0G7/_ ('V_P#\50!6NO!(_M.UN=,OI-/CC#"1(/EW XZ
M<>N3UZ>E:ESH*)HZ65@1&T4@E4NQP[]RQ')SFJG]N^(O^A.N?_ ^W_\ BJ/[
M=\1?]"=<_P#@?;__ !5 %'5=#UFZN[6YG8WX#EI+59=D*XQM^4GGG.3UK;L-
M'9+E[_4)!<7KC:#CY85_NIZ#WZFJ7]N^(O\ H3KG_P #[?\ ^*H_MWQ%_P!"
M=<_^!]O_ /%4 =&BA$5%& !@4M<W_;OB+_H3KG_P/M__ (JC^W?$7_0G7/\
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M^A.N?_ ^W_\ BJ/[=\1?]"=<_P#@?;__ !5 '245S?\ ;OB+_H3KG_P/M_\
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ML9CDXQ1%:W?;_+_@_@$KO3S_ ,_^!^)Q&K^+=>N4EG2.XLXK765M0D3J3,G
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M1V(7./QJXPE-VBKD3J1@KR=C?HKSN\^*UA&Y%JB3+V+*Z_TK*E^,%RKD1Z9
MR]B9&']*ZHX#$2^R<<LPP\=Y'K-%>2I\8+LL ^EVX'KYC?X5I6WQ8M'<"XB2
M-<\D!S_2G+ 8A?9".8X:7VCTBBN<T[QUX=U$E4U."-QVF)C_ "W8S71*RNH9
M6#*1D$'((KDG3G!VDK'9"I":O!W%HHHJ"PHHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ!I6C>%DMKW5DBL]6NE.5SE0<]$QQW&0*W?%?AX>)-(^R>:T;JX=/FPI/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8O%.K:AXDL5M=)NX]'D8JT\D1^?T;V7C@GUKM:\7TSQ1K^L/I^@6[10W%K(
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M %S6-=7/C[38_->WT_4%')6W.T@?\"Q6SX;\3VGB6U?RP\%W%\L\#\-&W?\
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M>F:BUT+U_*>T)W;4 4=B?Y=JVA%02HO72]FNMKZ,PJ3<VZRNM;73Z7MJF/\
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M:TZYCX>SFX\$Z>Q&-JLG_?)(_I73UQ5H\M22\V>A0ES4HR[I!11161J%%%%
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MEU]_0ZN7Q;!XWLIM$MX[BPO94WQ,X^5L=L@YY^E<9::21HE[J"3S+J^FW/\
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M>*=-UY)OLIFCDA&Z6*:,JR#MGJ.WK7/*E7@^=WTZ_@=,:N'J+D5M>GXFT
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MJL-5^:\_R?G8\^A+GBZ,]'^3\OS7E<\[O_%?B:\MK>YOKI-,TV[#F.2"/<6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45793981576928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001551152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">AbbVie Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3ASR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45793981392352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The Registrant is relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all registration fees. In connection with the securities offered hereby, the Registrant will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The Registrant will calculate the registration fee applicable to an offer of securities pursuant to this Registration Statement based on the fee payment rate in effect on the date of such fee payment.

An indeterminate amount of securities to be offered at indeterminate prices is being registered pursuant to this Registration Statement.
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45793982925088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Feb. 06, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MZ QG:LMYTYJ:0+*R;@<QDZJYU,-,=7/@.D&M'QB3UT!WF.[_$/X%4$L#!!0
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MWI(H2A(W IA;011A"+R-.((I  T8$D7=.7AT'@6[<RK8_\A>_ 102P,$%
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M)W43U76+BBTGW=$'/;^\.K_1;6F=NU7M.3R2+<=%&)=X]0U02P,$%     @
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M+GAM;%!+ 0(4 Q0    ( .J#3EIP8)!F[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .J#3EJ97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ ZH-.6DMPW[A" @  *P8  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .J#3EI]NLG[8 ,
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M;',O+G)E;'-02P$"% ,4    " #J@TY:4G%OM5T!  !( P  #P
M    @ &2%   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ZH-.6KMLZNRZ
M    &@,  !H              ( !'!8  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ ZH-.6J;\2ELC 0  WP0  !,
M ( !#A<  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      L "P#* @  8A@
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>16</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm255723d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm255723d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tm255723d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="tm255723d1_ex-filingfees.htm">tm255723d1_ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm255723d1_ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "tm255723d1_ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 16,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/ffd/2024q2": 3,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 15,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-25-014191-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-014191-xbrl.zip
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MSB9<,1WN6F"80# ==>]]T %#3B-,6A2_(FQN>V'=Z6K]^PDCZ;<!A$LBF+/
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>9F5E<RYH=&U02P4&      $  0!*    PPD

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>tm255723d1_ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
        </entity>
        <period>
            <startDate>2025-02-06</startDate>
            <endDate>2025-02-06</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-06</startDate>
            <endDate>2025-02-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-204">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-205">S-3ASR</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-206">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-207">0001551152</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-208">AbbVie Inc.</dei:EntityRegistrantName>
    <ffd:FormTp contextRef="rc" id="ixv-233">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-234">AbbVie Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-235">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-236">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-237">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-238">true</ffd:Rule457rFlg>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-239"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-240" unitRef="USD">0.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-241" unitRef="USD">0.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-242" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-243" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-244" unitRef="USD">0.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-245">The Registrant is relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all registration fees. In connection with the securities offered hereby, the Registrant will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The Registrant will calculate the registration fee applicable to an offer of securities pursuant to this Registration Statement based on the fee payment rate in effect on the date of such fee payment.

An indeterminate amount of securities to be offered at indeterminate prices is being registered pursuant to this Registration Statement.
</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
